Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Imjudo 300mg Injection 15ml
Manufacturer/Marketed By : ASTRAZENECA PHARMA INDIA LTD
$4737.35 $3884.64
Imjudo 300mg Injection 15ml is an advanced immunotherapy used in the treatment of certain types of cancer. It contains Tremelimumab, a type of monoclonal antibody that belongs to the pharmacological...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
TREMELIMUMAB
Active Pharmaceutical Ingredient
Imjudo 300mg Injection 15ml
$4,737.35
$3,884.64
Imjudo 300mg Injection 15ml is an advanced immunotherapy used in the treatment of certain types of cancer. It contains Tremelimumab, a type of monoclonal antibody that belongs to the pharmacological class called immune checkpoint inhibitors. This medicine is primarily used in combination with other cancer therapies to enhance the body’s immune response against cancer cells. It is classified under the therapeutic category of anti-cancer drugs and is commonly prescribed for conditions like liver cancer and mesothelioma. While Imjudo 300mg Injection 15ml has shown promising results in clinical settings, it must be used with caution. It is not recommended for individuals with severe autoimmune diseases or a history of organ transplant, as it may overstimulate the immune system. Imjudo 300mg Injection 15ml should always be administered under the supervision of an oncology specialist. Patients must be regularly monitored during treatment due to potential risks including immune-related reactions affecting the lungs, liver, or endocrine glands. Pregnant or breastfeeding women should avoid this medication unless clearly advised by their doctor.
Active Pharmaceutical Ingredient
Uses
• Unresectable hepatocellular carcinoma (a type of liver cancer), in combination with durvalumab.
• Malignant pleural mesothelioma (a rare cancer affecting the lining of the lungs), in combination therapies.
Benefits
This medicine works by helping the body’s immune system recognise and attack cancer cells more effectively. It does this by blocking a protein called CTLA-4 found on certain immune cells. Normally, this protein acts like a brake to prevent the immune system from overreacting. By blocking CTLA-4, Imjudo 300mg Injection 15ml removes this brake, allowing immune cells to stay active longer and fight off cancer cells more powerfully.
Side Effects
Common Side Effects:
Most Common Side Effects
• Severe diarrhoea or colitis
• Breathing difficulty or chest tightness (signs of pneumonitis)
• Yellowing of the skin or eyes (possible liver issues)
• Hormonal problems like thyroid imbalance
• Eye inflammation or vision problems
Common Side Effects
• Tiredness or fatigue
• Diarrhoea or abdominal pain
• Skin rash or itching
• Loss of appetite
• Joint or muscle pain
How To Use
Imjudo 300mg Injection 15ml is given as an intravenous infusion (IV) by a healthcare professional in a clinical setting. The dosage and schedule are decided based on the patient's weight, type of cancer, and overall health. It is not taken with food or at home. It is often given in combination with other medications like durvalumab, usually once every few weeks. Do not attempt to self-administer or alter the treatment schedule without medical guidance.
Safety Advice
• Breast Feeding: It is unknown whether Imjudo 300mg Injection 15ml passes into breast milk. Women are advised not to breastfeed while receiving this treatment and for some time after.
• Alcohol: There are no direct interactions known, but since Imjudo 300mg Injection 15ml affects the liver, alcohol use should be avoided or discussed with a doctor.
• Liver: Imjudo 300mg Injection 15ml may cause liver inflammation, leading to changes in liver enzymes. Liver function should be regularly monitored.
• Lungs: Imjudo 300mg Injection 15ml can cause inflammation of the lungs (pneumonitis). Patients should report symptoms like shortness of breath or cough immediately.
• Driving: Fatigue and dizziness may occur with Imjudo 300mg Injection 15ml, especially after infusions. Avoid driving if you feel unwell.
• Pregnancy: Imjudo 300mg Injection 15ml may harm an unborn baby and is not recommended during pregnancy. Use effective birth control during treatment and for at least 3 months after the last dose.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.